Drugs / Xinfeng capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01774877 | Jul 2013 → Jun 2014 | rheumatoid arthritis | The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xinfeng capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01774877 ↗ |
| Known as | XFC | “one group was administered Xinfeng capsule (XFC) plus the placebo of leflunomide and the other given leflunomide (LEF) plus the placebo of XFC for twelve weeks.” PMID 26591677 ↗ Oct 2015 |
| Modality | Traditional medicine (herbal / TCM) | “Xinfeng Capsule, a patent Chinese herbal medicine, has been used in the treatment of RA in recent years.” PMID 24299607 ↗ Nov 2013 |
| Route | Oral | “Xinfeng capsule:Three each time, 3 times a day, Oral,for 3 months” NCT01774877 ↗ |